No evidence to support CTLA-4 as a susceptibility gene in MS families: The Canadian Collaborative Study

Journal of Neuroimmunology

Volumn 123, Issue 1-2, 2002, Pages 193-198

  Dyment, D A ^a   Steckley, J L ^a   Willer, C J ^a   Armstrong, H ^b   Sadovnick, A D ^c   Risch, N ^d   Ebers, G C ^a,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Association; CTLA 4; Linkage; Multiple sclerosis

Indexed keywords

ALANINE; ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; HLA DR15 ANTIGEN; THREONINE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANADA; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; ETHNOLOGY; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOCONJUGATES; LINKAGE (GENETICS); MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC;

EID: 0036184219     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00493-3     Document Type: Article

References (41)

1. CTLA-4 and CD28: Similar proteins, neighbouring genes
2. Clustering of non-major histocompatibility complex susceptibility loci in human autoimmune diseases
3. Autoimmune disease in first-degree relatives of patients with multiple sclerosis: A UK survey
4. A second generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus
5. CTLA4 alanine-17 confers genetic susceptibility to Graves disease and to type 1 diabetes mellitus
6. A population-based study of multiple sclerosis in twins
7. A genetic basis for familial aggregation in multiple sclerosis
8. A full genome search in multiple sclerosis
9. Chapter 16: Animal model systems of MS
10. CTLA-4 mediates antigen-specific apoptosis of human T cells
11. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex
12. CTLA-4 promoter and exon 1 dimorphisms in multiple sclerosis
13. Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy
14. Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders: Report of 5 cases
15. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis
16. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune thyroidism
17. Genomewide scan of multiple sclerosis in Finnish multiplex families
18. IDDM12 (CTLA-4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent)
19. Molecular basis of T cell inactivation by CTLA-4
20. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule
21. The CTLA4 gene is associated with multiple sclerosis
22. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups
23. Multiple sclerosis and chronic inflammatory diseases: A case-control study
24. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes
25. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
26. Association of DRB1 * 04-DQB1 * 0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population
27. Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis
28. CTLA4 in multiple sclerosis: Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese
29. The future of genetic studies of complex human diseases
30. Epidemiology of multiple sclerosis: A critical overview
31. A population-based half-sib study of multiple sclerosis
32. The Canadian Collaborative project on genetic susceptibility to MS, phase 2: Rationale and method
33. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
34. Transmission test for disequilibrium and association
35. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus
36. Anti-myelin basic protein anti-proteolipid protein specific forms of multiple sclerosis
37. The affected-pedigree-member method of linkage analysis
38. An association between multiple sclerosis and type I diabetes mellitus
39. CTLA-4 gene polymorphism associated with Graves disease in a Caucasian population
40. T cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination